Annual CFI
$20.24 M
+$108.36 M+122.96%
31 December 2023
Summary:
Standard BioTools annual cash flow from investing activities is currently $20.24 million, with the most recent change of +$108.36 million (+122.96%) on 31 December 2023. During the last 3 years, it has fallen by -$19.74 million (-49.38%). LAB annual CFI is now -55.13% below its all-time high of $45.10 million, reached on 01 December 2016.LAB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$30.88 M
-$81.14 M-161.45%
30 September 2024
Summary:
Standard BioTools quarterly cash flow from investing activities is currently -$30.88 million, with the most recent change of -$81.14 million (-161.45%) on 30 September 2024. Over the past year, it has increased by +$19.04 million (+38.14%). LAB quarterly CFI is now -109.71% below its all-time high of $318.07 million, reached on 31 March 2024.LAB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$324.33 M
+$19.04 M+6.24%
30 September 2024
Summary:
Standard BioTools TTM cash flow from investing activities is currently $324.33 million, with the most recent change of +$19.04 million (+6.24%) on 30 September 2024. Over the past year, it has increased by +$250.73 million (+340.67%). LAB TTM CFI is now at all-time high.LAB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +123.0% | +38.1% | +340.7% |
| 3 y3 years | -49.4% | -1710.3% | +2890.4% |
| 5 y5 years | +328.8% | -5504.9% | +925.3% |
LAB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -49.4% | +123.0% | -109.7% | +77.7% | at high | +328.5% |
| 5 y | 5 years | -49.4% | +123.0% | -109.7% | +77.7% | at high | +328.5% |
| alltime | all time | -55.1% | +111.3% | -109.7% | +77.7% | at high | +277.7% |
Standard BioTools Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$30.88 M(-161.5%) | $324.33 M(+6.2%) |
| June 2024 | - | $50.26 M(-84.2%) | $305.29 M(+3.4%) |
| Mar 2024 | - | $318.07 M(-2524.9%) | $295.16 M(+1358.5%) |
| Dec 2023 | $20.24 M(-123.0%) | -$13.12 M(-73.7%) | $20.24 M(-72.5%) |
| Sept 2023 | - | -$49.93 M(-224.4%) | $73.60 M(-45.2%) |
| June 2023 | - | $40.13 M(-7.0%) | $134.26 M(-404.4%) |
| Mar 2023 | - | $43.15 M(+7.2%) | -$44.10 M(-50.0%) |
| Dec 2022 | -$88.13 M(+637.7%) | $40.24 M(+274.9%) | -$88.13 M(-32.0%) |
| Sept 2022 | - | $10.74 M(-107.8%) | -$129.52 M(-8.8%) |
| June 2022 | - | -$138.24 M(>+9900.0%) | -$141.96 M(+1699.0%) |
| Mar 2022 | - | -$868.00 K(-24.2%) | -$7.89 M(-33.9%) |
| Dec 2021 | -$11.95 M(-129.9%) | -$1.15 M(-32.9%) | -$11.95 M(+2.8%) |
| Sept 2021 | - | -$1.71 M(-59.1%) | -$11.62 M(-452.9%) |
| June 2021 | - | -$4.17 M(-15.3%) | $3.29 M(-81.3%) |
| Mar 2021 | - | -$4.92 M(+498.9%) | $17.59 M(-56.0%) |
| Dec 2020 | $39.98 M(-201.7%) | - | - |
| Dec 2020 | - | -$822.00 K(-106.2%) | $39.98 M(-0.7%) |
| Sept 2020 | - | $13.21 M(+30.5%) | $40.25 M(+19.8%) |
| June 2020 | - | $10.13 M(-42.0%) | $33.58 M(-377.9%) |
| Mar 2020 | - | $17.46 M(-3268.8%) | -$12.08 M(-69.3%) |
| Dec 2019 | -$39.30 M(-932.8%) | - | - |
| Dec 2019 | - | -$551.00 K(-108.4%) | -$39.30 M(+1.4%) |
| Sept 2019 | - | $6.55 M(-118.4%) | -$38.77 M(-12.9%) |
| June 2019 | - | -$35.54 M(+264.3%) | -$44.52 M(+832.3%) |
| Mar 2019 | - | -$9.76 M(>+9900.0%) | -$4.78 M(-201.2%) |
| Dec 2018 | $4.72 M(-73.3%) | -$19.00 K(-102.4%) | $4.72 M(+449.4%) |
| Sept 2018 | - | $802.00 K(-80.9%) | $859.00 K(+70.1%) |
| June 2018 | - | $4.20 M(-1696.6%) | $505.00 K(-581.0%) |
| Mar 2018 | - | -$263.00 K(-93.2%) | -$105.00 K(-100.6%) |
| Dec 2017 | $17.66 M | -$3.88 M(-965.8%) | $17.66 M(-50.0%) |
| Sept 2017 | - | $448.00 K(-87.5%) | $35.32 M(-21.0%) |
| June 2017 | - | $3.59 M(-79.5%) | $44.70 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $17.50 M(+26.9%) | $41.40 M(-8.2%) |
| Dec 2016 | $45.10 M(+75.2%) | $13.79 M(+40.4%) | $45.10 M(+24.7%) |
| Sept 2016 | - | $9.82 M(+3263.4%) | $36.16 M(-17.9%) |
| June 2016 | - | $292.00 K(-98.6%) | $44.02 M(+19.4%) |
| Mar 2016 | - | $21.20 M(+337.7%) | $36.88 M(+43.2%) |
| Dec 2015 | $25.74 M(-114.4%) | $4.84 M(-72.6%) | $25.74 M(-3.0%) |
| Sept 2015 | - | $17.68 M(-357.9%) | $26.55 M(+440.2%) |
| June 2015 | - | -$6.86 M(-168.1%) | $4.92 M(-110.4%) |
| Mar 2015 | - | $10.07 M(+78.2%) | -$47.08 M(-73.6%) |
| Dec 2014 | -$178.38 M(+547.1%) | $5.65 M(-243.0%) | -$178.38 M(+2.3%) |
| Sept 2014 | - | -$3.95 M(-93.3%) | -$174.42 M(-4.4%) |
| June 2014 | - | -$58.85 M(-51.5%) | -$182.53 M(+20.7%) |
| Mar 2014 | - | -$121.23 M(-1360.6%) | -$151.19 M(+448.5%) |
| Dec 2013 | -$27.57 M(-296.9%) | $9.62 M(-179.7%) | -$27.57 M(-30.4%) |
| Sept 2013 | - | -$12.06 M(-56.2%) | -$39.63 M(+77.9%) |
| June 2013 | - | -$27.52 M(-1249.0%) | -$22.28 M(-288.4%) |
| Mar 2013 | - | $2.40 M(-198.0%) | $11.83 M(-15.5%) |
| Dec 2012 | $14.00 M(-131.0%) | -$2.44 M(-146.2%) | $14.00 M(-34.6%) |
| Sept 2012 | - | $5.29 M(-19.7%) | $21.40 M(+1.9%) |
| June 2012 | - | $6.59 M(+44.1%) | $21.00 M(-213.8%) |
| Mar 2012 | - | $4.57 M(-7.8%) | -$18.45 M(-59.1%) |
| Dec 2011 | -$45.11 M(+3284.1%) | $4.96 M(+1.4%) | -$45.11 M(-10.5%) |
| Sept 2011 | - | $4.89 M(-114.9%) | -$50.40 M(-9.6%) |
| June 2011 | - | -$32.87 M(+48.8%) | -$55.76 M(+141.8%) |
| Mar 2011 | - | -$22.09 M(+6513.5%) | -$23.06 M(+1630.2%) |
| Dec 2010 | -$1.33 M(+93.8%) | -$334.00 K(-29.2%) | -$1.33 M(+33.4%) |
| Sept 2010 | - | -$472.00 K(+181.0%) | -$999.00 K(+89.6%) |
| June 2010 | - | -$168.00 K(-53.2%) | -$527.00 K(+46.8%) |
| Mar 2010 | - | -$359.00 K | -$359.00 K |
| Dec 2009 | -$688.00 K(-111.5%) | - | - |
| Dec 2008 | $6.00 M(-189.0%) | - | - |
| Dec 2007 | -$6.74 M(+129.0%) | - | - |
| Dec 2006 | -$2.94 M | - | - |
FAQ
- What is Standard BioTools annual cash flow from investing activities?
- What is the all time high annual CFI for Standard BioTools?
- What is Standard BioTools annual CFI year-on-year change?
- What is Standard BioTools quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Standard BioTools?
- What is Standard BioTools quarterly CFI year-on-year change?
- What is Standard BioTools TTM cash flow from investing activities?
- What is the all time high TTM CFI for Standard BioTools?
- What is Standard BioTools TTM CFI year-on-year change?
What is Standard BioTools annual cash flow from investing activities?
The current annual CFI of LAB is $20.24 M
What is the all time high annual CFI for Standard BioTools?
Standard BioTools all-time high annual cash flow from investing activities is $45.10 M
What is Standard BioTools annual CFI year-on-year change?
Over the past year, LAB annual cash flow from investing activities has changed by +$108.36 M (+122.96%)
What is Standard BioTools quarterly cash flow from investing activities?
The current quarterly CFI of LAB is -$30.88 M
What is the all time high quarterly CFI for Standard BioTools?
Standard BioTools all-time high quarterly cash flow from investing activities is $318.07 M
What is Standard BioTools quarterly CFI year-on-year change?
Over the past year, LAB quarterly cash flow from investing activities has changed by +$19.04 M (+38.14%)
What is Standard BioTools TTM cash flow from investing activities?
The current TTM CFI of LAB is $324.33 M
What is the all time high TTM CFI for Standard BioTools?
Standard BioTools all-time high TTM cash flow from investing activities is $324.33 M
What is Standard BioTools TTM CFI year-on-year change?
Over the past year, LAB TTM cash flow from investing activities has changed by +$250.73 M (+340.67%)